Professional Team

Bringing together seasoned experts from diverse fields to drive investment excellence

Tmind

CEO

Tmind is the founder and CEO of AnRain Investment, overseeing strategic planning, team building, and operational management. With extensive cross-market experience in financial investment, he is committed to building a research-driven, trust-based professional investment firm.

Pepper

Executive Assistant

Pepper handles daily operational support for the team, including schedule coordination, information research, and travel arrangements. Her efficient and meticulous work style makes her an indispensable connector for the team's smooth operation.

Ben

CFO

Ben oversees corporate financial management and investment analysis, combining rigorous accounting expertise with sharp investment judgment. He is responsible for constructing and maintaining the company's financial models, providing solid data support for investment decisions.

Daniel

Chief Legal Officer

Daniel is proficient in legal affairs across China, the U.S., and European jurisdictions, responsible for contract review, transaction structuring, and compliance risk control. His deep experience in cross-border legal frameworks provides solid legal safeguards for the company's global investment deployment.

Pei

Chief Architect

Pei's professional background spans architectural design, project management, and cost auditing. She brings spatial thinking and systems methodology to investment analysis, offering a unique perspective in real estate appraisal and engineering project due diligence.

David

CTO

David is responsible for the company's technical architecture, AI applications, and cybersecurity. He drives the integration of data analytics and intelligent tools into the investment research process while ensuring the security and stable operation of the company's information systems.

Audrey

Health Advisor

Audrey provides health management, medical report interpretation, and nutrition guidance to the team. Her focus extends beyond team well-being to professionally evaluating investment opportunities in the health and biotech sectors, transforming medical insights into effective inputs for investment research.